Cyclin-dependent Kinase 4 Inhibitors [MoA] - N0000193921

Pharmacologic Code	N0000193921
Pharmacologic Name	Cyclin-dependent Kinase 4 Inhibitors
Pharmacologic Uses	kinase inhibitor
Pharmacologic Concept	Mechanisms of Action - [MoA]
Pharmacologic Concept Description	This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

The table contains 1 products whose active ingredient are classified under the same pharmacologic class Cyclin-dependent Kinase 4 Inhibitors [MoA].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	73462-101	Cosela	Non-Proprietary Name: Trilaciclib	Injection, Powder, Lyophilized, For Solution	Intravenous	G1 Therapeutics, Inc.	ACTIVE